Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Predicting personalized cancer metastasis routes, biological mediators of metastasis and metastasis blocking therapies

A technology of cancer metastasis and cancer, applied in the direction of bioinformatics, biostatistics, biological systems, etc., can solve a lot of effort and cost, expensive, can not provide cancer spread to other tissues, etc., to reduce workload and cost Effect

Inactive Publication Date: 2018-12-21
IBM CORP
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, due to a lack of understanding of the molecular basis of metastasis, such conventional methods for predicting cancer prognosis or survival often do not provide sufficient information to prevent cancer from spreading to other tissues
Likewise, existing methods assume that metastasis from one tissue to another is the same from patient to patient
Furthermore, existing methods, as well as those in development, may require assaying many genes to predict prognosis, which is expensive and requires significant effort and expense in the clinical validation of new diagnoses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Predicting personalized cancer metastasis routes, biological mediators of metastasis and metastasis blocking therapies
  • Predicting personalized cancer metastasis routes, biological mediators of metastasis and metastasis blocking therapies
  • Predicting personalized cancer metastasis routes, biological mediators of metastasis and metastasis blocking therapies

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] Embodiments of the invention may provide the ability to predict metastasis of a patient's cancer from one tissue, organ or body part to another, and provide improved outcomes while reducing effort and cost.

[0027] Certain cancers have a tendency to spread to certain tissues. The process is not random. Embodiments of the invention can take advantage of the non-random nature of the progression of cancer from a primary state to a metastatic state, as the molecular network of cancer biomarkers correlates with the molecular network of genes that mediate metastasis. For example, the shortest path in a cancer cell's molecular network that connects a patient's dysregulated cancer gene to a set of known metastatic genes in a particular tissue predicts the most likely tissue where the cancer may spread.

[0028] allowable Figure 1-5 See examples of this pathway analysis in . exist Figure 1-5 In the analysis shown in , gene expression profiles from the cancer cell line MCF...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Predicting the metastasis of cancer in a patient from one tissue to another is disclosed. A computer-implemented method for predicting metastasis may comprise receiving an indication of at least one disrupted gene of the cancer; searching for data representing a gene-to-gene or protein-to-protein interaction network to determine the position of a received gene, wherein the data representing a gene-to-gene or protein-to-protein interaction network includes data that expresses the gene or the protein as a node of the network and expresses functional or physical interactions among the genes or proteins as an edge of the network; traversing the data representing a gene-to-gene or protein-to-protein interaction network specific for a type of the cancer type from a position of the received genein the network to a position of at least one gene involved in metastasis for a tissue type, organ or body part; determining at least one shortest path in the network between the received gene and theat least one gene involved in metastasis for the tissue type, organ or body part; generating a prediction of metastasis to the tissue type based on the at least one determined path; and generating anoutput display indicating a likelihood of spread of cancer to the tissue type, organ or body part.

Description

Background technique [0001] The present invention relates to techniques for predicting the spread (metastasis) of a patient's cancer from one tissue to another. [0002] Many methods for predicting the spread of cancer in a patient provide a prognostic prediction, such as whether the cancer is likely to spread to certain other tissues and increase the patient's risk of death or expected survival. However, conventional methods cannot predict whether a cancer will spread to a particular tissue or organ. Such conventional approaches may rely on correlations (comorbidity of cancers), cancers that tend to co-occur in patients based on medical records are considered more likely to spread in the same way. [0003] However, due to a lack of understanding of the molecular basis of metastasis, such conventional methods for predicting cancer prognosis or survival often do not provide sufficient information to prevent cancer from spreading to other tissues. Likewise, existing methods as...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G06F19/12G16H50/20G16B20/20G16B40/00G16H15/00
CPCG16B20/00G16B40/00G16H50/20G16H15/00G16B20/20G16B5/20
Inventor G·H·西沃S·阿塞法G·A·斯托洛维茨基
Owner IBM CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products